TB advocates encourage the Global Antimicrobial Resistance Innovation Fund to prioritize research and development for drug-resistant TB.

TB advocates encourage the Philippines Food and Drug Administration to approve delamanid, an important treatment option for people with multidrug-resistant TB.

Médecins Sans Frontières (MSF) urges Johnson & Johnson to ensure widespread access to bedaquiline for the treatment of multidrug-resistant TB.

The document is meant to serve as both a call to action and a plan for coordinating communications and activities to stop the attack on people’s lives and human rights in middle-income countries.

A coalition of Indian activists delivered a statement at the 6th Meeting of the BRICS Health Ministers in New Delhi, 15–16 December 2016.

The United Nations General Assembly has agreed to hold a High-Level Meeting on TB in 2018.

A regional coalition of TB activists working at a domestic and regional level to increase funding for TB programs, promote the right to health, and press for comprehensive and integrated TB prevention, diagnosis, care and support.

Civil society groups appeal to medicines regulators and governments on the occasion of the 17th International Conference of Drug Regulatory Authorities.

Médecins Sans Frontières (MSF) expressed concerns about the Global Fund’s policies on allocation, co-financing, and transition.

A resource to efficiently and proactively communicate to country governments the diagnostic tests that are worthy and indeed essential for approval and use is needed.